Wellness Communications Corporation
366A・Growth Market・Services
Wellness Communications Corporation
366A・Growth Market・Services
Health Checkup Solutions Business
Core business providing network health checkup services for corporations and health insurance societies
| Period | Current | Previous | Change |
|---|---|---|---|
| Net sales (FY2026, ending March 2026) | ¥13,018 million | ¥12,539 million (FY2025, ending March 2025, non-consolidated) | ↑ |
| Operating profit (FY2026, ending March 2026) | ¥379 million | ¥293 million (FY2025, ending March 2025, non-consolidated) | ↑ |
| Number of service users (full year, FY2026, ending March 2026) | 398,000 people (39.8万人) | 388,897 cases (shipment volume, FY2025, ending March 2025) | ↑ |
| Share of consolidated net sales (FY2026, ending March 2026) | Approximately 88% | - | — |
Business Details
The core of this business is the Network Health Checkup Service (NW Kenshin), which provides one-stop services for scheduling, payment settlement, and consolidation of health checkup results based on the Industrial Safety and Health Act. Through the proprietary platform "i-Wellness," the company standardizes, validates, and delivers health checkup results. The business is primarily deployed among large enterprises with 1,000 or more employees, and also promotes higher value-added services such as cancer screening and gynecological examinations, as well as operational efficiency improvements through AI-OCR and generative AI utilization. This is the flagship segment, accounting for approximately 88% of consolidated net sales.
Recent Overview
Promoted higher value-added cancer/gynecological screening and strengthened operations through AI utilization
In FY2026 (ending March 2026), in response to the diversification of client companies' health challenges, the company enhanced cancer screening and gynecological examinations, creating opportunities for various health checkups. In the health checkup results data conversion process, the company promoted systemization investment utilizing generative AI in addition to AI-OCR (Patent No. 7304604), achieving operational excellence. The number of service users reached 398,000 for the full year, and the segment achieved net sales of ¥13,018 million and operating profit of ¥379 million.
Key Products
Growth Drivers
- Mandatory health checkup implementation under the Industrial Safety and Health Act (stable statutory demand)
- Expansion of corporate investment in health management due to mandatory human capital information disclosure
- Increase in customer unit price through expansion of high value-added services such as cancer screening and gynecological examinations
- Operational efficiency improvements and cost reduction through AI-OCR and generative AI utilization (Patent No. 7304604 obtained)
- Deepening penetration of the large enterprise market and new development of the mid-sized and small-to-medium enterprise market
- Commencement of delivery of health checkup results data on Growbase from FY2027 (ending March 2027), strengthening collaboration with the cloud business
Risks
- Downward pressure on average sales unit price due to an increase in health checkup cases with fewer examination items
- Risk of review of health checkup eligibility age and examination items due to deteriorating finances of health insurance societies
- Seasonal fluctuation risk, as health checkup demand peaks in summer through autumn (concentrated in Q2 and Q3)
- Fluctuation in working capital requirements due to a procurement structure in which payments to medical institutions precede receipts
- Price competition risk from competitors (welfare benefit companies, occupational health institutions, etc.)
Last updated: June 25, 2026